Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 2, 2009, Pages 235-243

  Olthoff, Christine M G ^a   Hoevenaars, Juliette G M M ^b   van den Borne, Bart W ^b   Webers, Carroll A B ^b   Schouten, Jan S A G ^b  

^a Cologne Hospitals ^*  (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Determinants; Glaucoma; Non adherence; Prevalence

Indexed keywords

ACECLIDINE; AGENTS ACTING ON THE EYE; ANTIGLAUCOMA AGENT; BEFUNOLOL; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; CARTEOLOL; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; EPINEPHRINE PLUS GUANETHIDINE; EYE DROPS; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; METOPROLOL PLUS PILOCARPINE; TIMOLOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DISEASE DURATION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; SOCIAL PSYCHOLOGY;

ADMINISTRATION, TOPICAL; AGED; ANTIHYPERTENSIVE AGENTS; DRUG COSTS; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PREVALENCE; PSYCHOLOGY; QUESTIONNAIRES; RISK FACTORS; SELF ADMINISTRATION;

EID: 57949090530     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0944-y     Document Type: Article

References (47)

1. Busche S, Gramer E (1997) Verbesserung der Augentropfenapplikation und Compliance bei Glaukompatienten; eine klinische Studie. Klin Monatsbl Augenheilkd 211:257-262
2. Forsman E, Kivel T, Vesti E (2007) Lifetime visual disability in open-angle glaucoma and ocular hypertension. J Glaucoma 16:313-319
3. Konstas AGP, Maskaleris G, Gratsonidis S, Sardelli C (2000) Compliance and viewpoint of glaucoma patients in Greece. Eye 14:752-756
4. Lee DA, Fechtner RD, Fiscella RG, Singh K, Stewart WC (2000) Emerging perspectives on glaucoma: Highlights of a roundtable discussion. Am J Ophthalmol 130:S1-S11
5. Zimmerman TJ, Zalta AH (1983) Facilitating patient compliance in glaucoma therapy. Surv Ophthalmol 28:252-257
6. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes; a meta-analysis. Med Care 40:794-811
7. Deokule S, Sadiq S, Shah S (2004) Chronic open angle glaucoma: Patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthal Physiol Opt 24:9-15
8. Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J (1998) Patient noncompliance in the managed care setting; the case of medical therapy for glaucoma. Med Care 36:357-369
9. Olthoff CMG, Schouten JSAG, Van de Borne BW, Webers CAB (2005) Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension. Ophthalmology 112:953-961
10. Rotchford AP, Murphy KM (1998) Compliance with timolol treatment in glaucoma. Eye 12:234-236
11. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW (2003) Compliance barriers in glaucoma: A systematic classification. J Glaucoma 12:393-398
12. Taylor S, Galbraith S, Mills R (2002) Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study. J Ocul Pharmacol Ther 18:401-409
13. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B (2006) Patient-reported behavior and problems in using glaucoma medications. Ophthalmology 113:431-436
14. Elliot R, Barber N, Horne R (2005) Cost-effectiveness of adherence-enhancing interventions: A quality assessment of the evidence. Ann Pharmacother 39:508-515
15. Meertens RM, Schaalma H, Brug J, De Vries N (2000) Determinanten van gedrag [Determinants of behavior]. In: Brug J, Schaalma H, Kok G, Meertens RM, Van der Molen HT (Eds) Gezondheidsvoorlichting en Gedragsverandering; een Planmatige Aanpak [Health promotion and behavior change: A systematic approach]. Van Gorcum, Assen Netherlands, pp 55-72
16. Amon M, Menapace R, Wedrich A, Radax U (1990) Aspekte der Betreuung von Glaukompatienten und deren Auswirkung auf die Compliance. Spektrum Augenheilkd 4:5-8
17. Bour T, Blanchard F, Segal A (1993) [Therapeutic observance and life of patients with primary open-angle glaucoma. Apropos of 341 cases in the department of Marne]. J Fr Ophtalmol 16:380-391(in French)
18. Chang J, Lee D, Petursson G, Spaeth G, Zimmerman T, Hoskins H, Mills R, Brown R, Kass M, Lue J (1991) The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J Ocul Pharmacol 7:117-124
19. Laster S, Martin J, Fleming J (1996) The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc 67:654-658
20. MacKean JM, Elkington AR (1983) Compliance with treatment of patients with chronic open-angle glaucoma. Br J Ophthalmol 67:46-49
21. Patel SC, Spaeth GL (1995) Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26:233-236
22. Bloch S, Rosenthal AR, Friedman DS, Caldarolla P (1977) Patient compliance in glaucoma. Br J Ophthalmol 61:531-534
23. Winfield AJ, Jessiman D, Esakowitz L (1990) A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 74:477-480
24. Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J (1993) Treatment for glaucoma: Adherence by the elderly. Am J Public Health 83:711-716
25. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J (1986) Compliance with topical pilocarpine treatment. Am J Ophthalmol 101:515-523
26. DiMatteo MR (2004) Variations in patients' adherence to medical recommendations; a quantitative review of 50 years of research. Med Care 42:200-209
27. Oldenmenger W, Echteld M, Wit de R, Sillevis Smit P, Stronks D, Stoter G, Rijt van der C (2007) Analgesic adherence measurement in cancer patients: Comparison between electronic monitoring and diary. J Pain Symptom Manage 34:639-647
28. Hugen P, Langebeek N, Burger D, Zomer B, Leusen van R, Schuurman R, Koopmans P, Hekster Y (2002) Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr 30:324-334
29. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM (1998) Risk factors for noncompliance with glaucoma follow-up visits in a residents's eye clinic. Ophthalmology 105:2105-2111
30. Brown M, Brown G, Spaeth G (1984) Improper topical self-administration of ocular medication among patients with glaucoma. Can J Ophthalmol 19:2-5
31. Dietlein TS (2006) Glaukom im Alter; Barrieren fur Aufklaerung und Compliance. Ophthalmologe 103:755-758
32. Robin AL, Covert D (2005) Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology 112:863-868
33. Robin A, Novack G, Covert D, Crockett R, Marcic T (2007) Adherence in glaucoma: Objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol 144:533-540
34. Mansukani SS (2002) Improving adherence to drug-treatment regimens for glaucoma. Manag Care 11:49-53
35. Kripalani S, Yao X, Haynes B (2007) Interventions to enhance medication adherence in chronic medical conditions; a systematic review. Arch Intern Med 167:540-550
36. Dulmen van S, Sluijs E, Dijk van L, Ridder de D, Heerdink R, Bensing J (2007) Patient adherence to medical treatment: A review of reviews. BMC Health Serv Res 7:55
37. Stewart WC, Konstas AGP, Pfeiffer N (2004) Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther 20:461-469
38. Buller AJ, Morgan LH, Hercules BL (2007) Patients prefer one-daily glaucoma drops. Graefes Arch Clin Exp Ophthalmol 245:293-294
39. Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB (2003) Patient preferences for eye drop characteristics. Arch Ophthalmol 121:540-546
40. Sclar D, Skaer T, Chin A (1991) Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma. Clin Ther 13:396-400
41. Norell SE (1979) Improving medication compliance: A randomised clinical trial. Br Med J 2:1031-1033
42. Flowers B, Wand M, Piltz-Seymour J, Berke S, Day D, Teague J, Smoot T, Landry T, Bergamini M, Mallick S (2006) Patients' and physicians' perceptions of the Travoprost dosing aid: An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension. Clin Ther 28:1803-1811
43. Boden C, Sit A, Weinreb RN (2006) Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops. J Glaucoma 15:30-34
44. Kharod BV, Johnson PB, Nesti HA, Rhee DJ (2006) Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients. J Glaucoma 15:244-247
45. Lefante JJ, Harmon GN, Roy W, Fontenot S, Brown K, Webber L (2005) The effect of medication reviews in a rural community pharmacy assistance program: The cenla medication access program. J Pharm Pract 18:486-492
46. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B (1998) Effectiveness of interventions to improve patient compliance; a meta-analysis. Med Care 36:1138-1161
47. Peterson A, Takiya L, Finley R (2003) Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 60:657-665